Transcat (NASDAQ:TRNS – Get Free Report) is expected to be announcing its Q3 2026 results after the market closes on Tuesday, February 3rd. Analysts expect the company to announce earnings of $0.36 per share and revenue of $80.9850 million for the quarter. Individuals can check the company’s upcoming Q3 2026 earning summary page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 4:30 PM ET.
Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings data on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The business had revenue of $82.27 million during the quarter, compared to the consensus estimate of $79.51 million. Transcat had a return on equity of 6.81% and a net margin of 3.75%. On average, analysts expect Transcat to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Transcat Stock Performance
Shares of TRNS opened at $60.31 on Monday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.43 and a quick ratio of 2.06. The company’s fifty day moving average price is $58.90 and its 200 day moving average price is $68.71. The company has a market capitalization of $562.69 million, a PE ratio of 49.43 and a beta of 0.79. Transcat has a one year low of $50.23 and a one year high of $97.08.
Institutional Investors Weigh In On Transcat
Analysts Set New Price Targets
Several equities research analysts recently commented on TRNS shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a research report on Monday, December 29th. Northland Securities set a $95.00 price target on Transcat in a research report on Thursday, October 23rd. Finally, Zacks Research upgraded shares of Transcat from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Transcat has an average rating of “Buy” and a consensus target price of $105.33.
View Our Latest Stock Report on TRNS
About Transcat
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
- Five stocks we like better than Transcat
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Buy this Gold Stock Before May 2026
- This is the Exact Moment the AI Boom Will End
- Washington knows what’s coming. Do you?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
